文献速递免疫规划传染病防控与疫情报告

使用新型尿抗原检测试验评估西班牙住院肺炎球菌肺炎中PCV13血清型的负担:CAPA研究

The burden of PCV13 serotypes in hospitalized pneumococcal pneumonia in Spain using a novel urinary antigen detection test. CAPA study.
PubMed 文献 · Vaccine · 2017-08-18

2011至2014年在西班牙3家医院开展前瞻性研究,纳入1258例住院社区获得性肺炎(CAP)成人,用血清型特异性尿抗原检测等方法确认病原。368例(29.3%)为肺炎球菌肺炎,其中约60%由PCV13血清型引起(侵袭性 episodes 74.6% vs 非侵袭性 57.4%),PCV7血清型占3.5%。研究期间PCV13血清型分布无显著变化,作者认为儿童接种对成人的间接保护不足,鼓励实施成人肺炎球菌疫苗接种策略。

要点

  • 1258例住院CAP成人中368例(29.3%)确诊肺炎球菌肺炎,侵袭性疾病占17.7%。
  • 任何原因CAP中17.6%由PCV13血清型引起,PCV7血清型占3.5%。
  • 肺炎球菌CAP中约60%由PCV13血清型引起,侵袭性 episodes 为74.6%,非侵袭性为57.4%。

核心结论

  • PCV13血清型在合并基础疾病的成人和健康成人中均引起相当比例的CAP,2011至2014年由PCV7或PCV13血清型引起的病例无显著变化,提示儿童接种的间接保护不足。
  • 作者鼓励实施成人肺炎球菌疫苗接种策略以减少肺炎球菌感染的发生。

研究设计与样本

  • 2011至2014年在西班牙3家医院开展的前瞻性研究,纳入住院的免疫功能正常的CAP成人。
  • 采用血清型特异性尿抗原检测试验(UAD test)、Binax Now和常规培养进行微生物学确认。

主要发现

  • 共纳入1258例成人,368例(29.3%)确诊肺炎球菌肺炎,其中侵袭性疾病占17.7%。
  • 任何原因CAP中17.6%由PCV13血清型引起,PCV7血清型占3.5%。
  • 肺炎球菌CAP中约60%由PCV13血清型引起,侵袭性 episodes 为74.6%,非侵袭性为57.4%。
  • 侵袭性疾病中最常见的血清型为1、3、7F、19A和14。
  • 研究期间PCV13血清型分布无显著差异;合并症间PCV13血清型比例相似,无基础疾病者略高。

临床怎么用

  • 原文未据此给出具体临床推荐;作者在结论中鼓励实施成人肺炎球菌疫苗接种策略以减少肺炎球菌感染的发生。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Streptococcus pneumoniae serotypes distribution in community-acquired pneumonia (CAP) requiring hospitalization in adults after introduction of PCV13 in children is not well known. Our aim was to evaluate the distribution of serotypes in pneumococcal pneumonia according to risk factors and comorbidity conditions after the introduction of PCV13 in children in 2010. METHODS: A prospective study from 2011 to 2014 was performed in immunocompetent adults hospitalized with CAP in 3 Spanish hospitals. Microbiological confirmation was obtained using a serotype specific urinary antigen detection test (UAD test), Binax Now and conventional cultures. RESULTS: 1258 adults were enrolled and pneumococcal pneumonia (invasive disease in 17.7%) was confirmed in 368 (29.3%) and 17.6% of the any-cause CAP were caused by PVC13 serotypes (3.5% PCV7 serotypes). Around 60% of pneumococcal CAP were caused by PCV13 serotypes (74.6% in invasive episodes vs 57.4% in non-invasive ones). The most prevalent serotypes in invasive disease were 1, 3, 7F, 19A and 14. No significant differences were observed in the distribution of PCV13 serotypes across the study periods. Regarding comorbidity, the rate of PCV13 serotypes was similar among them, and it was slightly higher in those with no underlying conditions. CONCLUSIONS: Serotypes included in PCV13 caused a significant proportion of CAP in adults with underlying conditions and in healthy adults, with no significant changes in cases due to PCV7 or PCV13 from 2011 to 2014, suggesting an insufficient indirect protection from childhood vaccination. Strategies for implementing pneumococcal vaccination of adults are encouraged to reduce the incidence of pneumococcal episodes.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Menéndez R, España PP, Pérez-Trallero E, et al. The burden of PCV13 serotypes in hospitalized pneumococcal pneumonia in Spain using a novel urinary antigen detection test. CAPA study. Vaccine. 2017. PMID: 28823622. doi:10.1016/j.vaccine.2017.08.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。